FDA Hits Aesica Over Quality Controls, Record-Keeping Post author:Sam Post published:April 19, 2017 Post category:Drug Industry Daily The FDA has cited contract manufacturer Aesica for quality and record-keeping problems. Source: Drug Industry Daily You Might Also Like Novartis Partners With Dunad Therapeutics to Develop Protein Degradation Therapies November 3, 2021 AdComm Approves of FDA Plans to Further Develop and Expand KASA Program November 3, 2022 House Fails to Pass ACA Repeal Bill March 24, 2017